Brain macromolecules: In vivo measurement by proton magnetic resonance spectroscopy

Neuroscientist

Volumn 2, Issue 6, 1996, Pages 309-312

  Graham, Glenn D ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

Brain; Human; Lipids; Nuclear magnetic resonance; Proteins

Indexed keywords

EID: 0000409125     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200607     Document Type: Review

References (29)

1. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191-247.
2. Graham GD, Kalvach P, Blamire AM, Brass LM, Fayad PB, Prichard JW. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995;26:225-229.
3. Frahm J, Merboldt K-D, Hanicke W. Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987;72:502-508.
4. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93.
5. Posse S, Schuknecht B, Smith ME, van Zijl PCM, Herschkowitz N, Moonen CTW. Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr 1993;17:1-14.
6. Behar KL, Ogino T. Assignment of resonances in the 1H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy. Magn Reson Med 1991;17:285-303.
7. 1H NMR spectrum of rat brain. Magn Reson Med 1993;30:38-44.
8. Behar KL, Rothman DL, Spencer DD, Petroff OAC. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302.
9. 1H MRS. Magn Reson Med 1991;19:191-198.
10. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn Reson Med 1993;29:546-550.
11. 1H MR spectra of neutrophils. Magn Reson Med 1994;31:212-217.
12. Silver MS, Joseph RI, Hoult DI. Highly selective π/2 and π pulse generation. J Magn Reson 1984;59:347-351.
13. Hwang J-H, Graham GD, Behar KL, Alger JR, Prichard JW, Rothman DL. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn Reson Med 1996;35:633-639.
14. Graham GD, Blamire AM, Howseman AM, et al. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 1992;23:333-340.
15. Garcia JH. The neuropathology of stroke. Hum Pathol 1975;6:583-598.
16. Petroff OAC, Graham GD, Blamire AM, et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 1992;42:1349-1354.
17. Newsholme P, Gordon S, Newsholme EA. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 1987;242:631-636.
18. Newsholme P, Newsholme EA. Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem J 1989;261:211-218.
19. Lopez-Villegas D, Lenkinski RE, Wehrli SL, Ho W-Z, Douglas SD. Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn Reson Med 1995;34:32-38.
20. 13C]glucose infusion. Magn Reson Med 1991;21:302-307.
21. Graham GD, Rothman DL, Hwang J-H, Blamire AM, Prichard JW. Spectroscopic assessment of alterations in lipids and small molecule metabolites in human brain after stroke. Proceedings of the Society of Magnetic Resonance, Second Meeting, 1994:187.
22. Graham GD, Hwang J-H, Rothman DL, Prichard JW. Alterations in cerebral macromolecules after human stroke [abstract]. Stroke 1996;27:182.
23. Graham GD, Hwang J-H, Rothman DL, Prichard JW. Spatial correlation of lactate and lipid signals in subacute cerebral infarction in humans. Proceedings of the Society of Magnetic Resonance, Third Meeting, 1995:136.
24. Bowes MP, Rothlein R, Fagan SC, Zivin JA. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 1995;45:815-819.
25. Larsson HBW, Christiansen P, Jensen M, et al. Localized in vivo proton spectroscopy in the brains of patients with multiple sclerosis. Magn Reson Med 1991;22: 23-31.
26. Narayana PA, Wolinsky JS, Jackson EF, McCarthy M. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques. J Magn Reson Imaging 1992;2: 263-270.
27. Koopmans RA, Li DKB, Zhu G, Allen PS, Penn A, Pary DW. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products. Lancet 1993;341:631-632.
28. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
29. Petroff OAC, Rothman DL, Behar KL. Metabolite and macromolecule changes within the MS plaque measured in vivo with serial 1H NMR spectroscopy. Proceedings of the Society of Magnetic Resonance, Second Meeting, 1994:586.